BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 20833724)

  • 1. Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- mice.
    Wilhelm AJ; Zabalawi M; Owen JS; Shah D; Grayson JM; Major AS; Bhat S; Gibbs DP; Thomas MJ; Sorci-Thomas MG
    J Biol Chem; 2010 Nov; 285(46):36158-69. PubMed ID: 20833724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity.
    Wilhelm AJ; Zabalawi M; Grayson JM; Weant AE; Major AS; Owen J; Bharadwaj M; Walzem R; Chan L; Oka K; Thomas MJ; Sorci-Thomas MG
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):843-9. PubMed ID: 19286630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice.
    Black LL; Srivastava R; Schoeb TR; Moore RD; Barnes S; Kabarowski JH
    J Immunol; 2015 Nov; 195(10):4685-98. PubMed ID: 26466956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice.
    Sorci-Thomas MG; Zabalawi M; Bharadwaj MS; Wilhelm AJ; Owen JS; Asztalos BF; Bhat S; Thomas MJ
    Biochim Biophys Acta; 2012 Mar; 1821(3):502-12. PubMed ID: 21944998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-Free Apolipoprotein A-I Reduces Progression of Atherosclerosis by Mobilizing Microdomain Cholesterol and Attenuating the Number of CD131 Expressing Cells: Monitoring Cholesterol Homeostasis Using the Cellular Ester to Total Cholesterol Ratio.
    Kaul S; Xu H; Zabalawi M; Maruko E; Fulp BE; Bluemn T; Brzoza-Lewis KL; Gerelus M; Weerasekera R; Kallinger R; James R; Zhang YS; Thomas MJ; Sorci-Thomas MG
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27821400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism.
    Hedrick CC; Hassan K; Hough GP; Yoo JH; Simzar S; Quinto CR; Kim SM; Dooley A; Langi S; Hama SY; Navab M; Witztum JL; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1946-52. PubMed ID: 10938016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol.
    Zabalawi M; Bhat S; Loughlin T; Thomas MJ; Alexander E; Cline M; Bullock B; Willingham M; Sorci-Thomas MG
    Am J Pathol; 2003 Sep; 163(3):1201-13. PubMed ID: 12937162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor.
    Moore RE; Kawashiri MA; Kitajima K; Secreto A; Millar JS; Pratico D; Rader DJ
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1914-20. PubMed ID: 12933536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and skin cholesterol in LDLr-/-, apoA-I-/- mice: link between cholesterol homeostasis and self-tolerance?
    Zabalawi M; Bharadwaj M; Horton H; Cline M; Willingham M; Thomas MJ; Sorci-Thomas MG
    J Lipid Res; 2007 Jan; 48(1):52-65. PubMed ID: 17071966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of ApoA-I in ApoEKO Mice Causes Skin Xanthomas, Worsening of Inflammation, and Increased Coronary Atherosclerosis in the Absence of Hyperlipidemia.
    Busnelli M; Manzini S; Colombo A; Franchi E; Bonacina F; Chiara M; Arnaboldi F; Donetti E; Ambrogi F; Oleari R; Lettieri A; Horner D; Scanziani E; Norata GD; Chiesa G
    Arterioscler Thromb Vasc Biol; 2022 Jul; 42(7):839-856. PubMed ID: 35587694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-I Modulates Atherosclerosis Through Lymphatic Vessel-Dependent Mechanisms in Mice.
    Milasan A; Jean G; Dallaire F; Tardif JC; Merhi Y; Sorci-Thomas M; Martel C
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nevirapine and efavirenz on HDL cholesterol levels and reverse cholesterol transport in mice.
    Tohyama J; Billheimer JT; Fuki IV; Rothblat GH; Rader DJ; Millar JS
    Atherosclerosis; 2009 Jun; 204(2):418-23. PubMed ID: 18990393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15.
    Yang CH; Tian L; Ling GS; Trendell-Smith NJ; Ma L; Lo CK; Stott DI; Liew FY; Huang FP
    Eur J Immunol; 2008 Jun; 38(6):1664-76. PubMed ID: 18465774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT4 Regulates the CD8
    Taghavie-Moghadam PL; Waseem TC; Hattler J; Glenn LM; Dobrian AD; Kaplan MH; Yang Y; Nurieva R; Nadler JL; Galkina EV
    J Immunol; 2017 Nov; 199(10):3453-3465. PubMed ID: 29055004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of D-4F on vasodilation and vessel wall thickness in hypercholesterolemic LDL receptor-null and LDL receptor/apolipoprotein A-I double-knockout mice on Western diet.
    Ou J; Wang J; Xu H; Ou Z; Sorci-Thomas MG; Jones DW; Signorino P; Densmore JC; Kaul S; Oldham KT; Pritchard KA
    Circ Res; 2005 Nov; 97(11):1190-7. PubMed ID: 16224061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantigen-specific TGFbeta-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells.
    DiPaolo RJ; Brinster C; Davidson TS; Andersson J; Glass D; Shevach EM
    J Immunol; 2007 Oct; 179(7):4685-93. PubMed ID: 17878367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.
    Park JG; Xu X; Cho S; Lee AH
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1772-81. PubMed ID: 27417587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor.
    Masson D; Koseki M; Ishibashi M; Larson CJ; Miller SG; King BD; Tall AR
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2054-60. PubMed ID: 19815817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation.
    Bu DX; Tarrio M; Maganto-Garcia E; Stavrakis G; Tajima G; Lederer J; Jarolim P; Freeman GJ; Sharpe AH; Lichtman AH
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1100-7. PubMed ID: 21393583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired Autophagy in CD11b
    Clement M; Raffort J; Lareyre F; Tsiantoulas D; Newland S; Lu Y; Masters L; Harrison J; Saveljeva S; Ma MKL; Ozsvar-Kozma M; Lam BYH; Yeo GSH; Binder CJ; Kaser A; Mallat Z
    Circ Res; 2019 Nov; 125(11):1019-1034. PubMed ID: 31610723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.